Li Z, Brendel M
Mol Gen Genet. 1993; 241(5-6):680-4.
PMID: 8264542
DOI: 10.1007/BF00279911.
Frei 3rd E, Holden S, GONIN R, Waxman D, Teicher B
Cancer Chemother Pharmacol. 1993; 33(2):113-22.
PMID: 8261570
DOI: 10.1007/BF00685328.
Reeve J, Wright K, Workman P
Br J Cancer. 1984; 50(2):153-8.
PMID: 6466534
PMC: 1976874.
DOI: 10.1038/bjc.1984.157.
BERGSAGEL D, Cowan D, Hasselback R
Can Med Assoc J. 1972; 107(9):851-5.
PMID: 4653931
PMC: 1940819.
Frei 3rd E, Cucchi C, Rosowsky A, Tantravahi R, Bernal S, Ervin T
Proc Natl Acad Sci U S A. 1985; 82(7):2158-62.
PMID: 3856890
PMC: 397512.
DOI: 10.1073/pnas.82.7.2158.
Positive correlation between decreased cellular uptake, NADPH-glutathione reductase activity and adriamycin resistance in Ehrlich ascites tumor lines.
Scheulen M, Hoensch H, Kappus H, Seeber S, SCHMIDT C
Arch Toxicol. 1987; 60(1-3):154-7.
PMID: 3619636
DOI: 10.1007/BF00296970.
Development of alkylating agent-resistant human tumor cell lines.
Teicher B, Frei 3rd E
Cancer Chemother Pharmacol. 1988; 21(4):292-8.
PMID: 3370736
DOI: 10.1007/BF00264194.
Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.
Bose R, Lam H
Cancer Chemother Pharmacol. 1988; 21(1):14-8.
PMID: 3342461
DOI: 10.1007/BF00262731.
Clinical management of cytotoxic drug overdose.
Thomas L, Mertens M, von dem Borne A, van Boxtel C, Veenhof C, Veies E
Med Toxicol Adverse Drug Exp. 1988; 3(4):253-63.
PMID: 3054425
DOI: 10.1007/BF03259938.
Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
Mann S, Andrews P, Howell S
Cancer Chemother Pharmacol. 1990; 25(4):236-40.
PMID: 2295111
DOI: 10.1007/BF00684878.
Molecular mechanisms of drug resistance.
Hayes J, Wolf C
Biochem J. 1990; 272(2):281-95.
PMID: 1980062
PMC: 1149697.
DOI: 10.1042/bj2720281.
Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
Matsumoto T, Endoh K, Akamatsu K, Kamisango K, Mitsui H, Koizumi K
Br J Cancer. 1991; 64(1):41-6.
PMID: 1854626
PMC: 1977319.
DOI: 10.1038/bjc.1991.236.
Resistance to cytostatic drugs at the cellular level.
Vendrik C, Bergers J, De Jong W, Steerenberg P
Cancer Chemother Pharmacol. 1992; 29(6):413-29.
PMID: 1568284
DOI: 10.1007/BF00684841.
